Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.926 |
27 |
1
|
2003 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
18 |
1
|
2010 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
17 |
1
|
2010 |
2019 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.060 |
None |
0.833 |
6 |
2
|
2008 |
2019 |
Dyslipidemias
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
471
|
184
|
0.350 |
None |
0.833 |
6 |
|
2007 |
2019 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.040 |
None |
1.000 |
4 |
3
|
2017 |
2019 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.040 |
None |
0.750 |
4 |
|
2011 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2018 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
945
|
50
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2018 |
Retinal Diseases
|
group |
Eye Diseases
|
Disease or Syndrome
|
714
|
56
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.030 |
None |
1.000 |
3 |
1
|
2016 |
2018 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.310 |
None |
1.000 |
2 |
|
2010 |
2011 |
Renal glomerular disease
|
group |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
221
|
7
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.310 |
None |
1.000 |
2 |
|
2011 |
2013 |
Dyschondroplasias
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
24
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Esophageal Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
19
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Disorder of eye
|
group |
Eye Diseases
|
Disease or Syndrome
|
400
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Giant Cell Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
76
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Musculoskeletal Diseases
|
group |
Musculoskeletal Diseases
|
Disease or Syndrome
|
38
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Periodontal Diseases
|
group |
Stomatognathic Diseases
|
Disease or Syndrome
|
326
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Complications of Diabetes Mellitus
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
240
|
35
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.400 |
None |
0.958 |
24 |
|
2006 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
12 |
3
|
2010 |
2019 |